Sort
48,018 grants matching “immunotherapy”
Project 1: Siglec15 as a new target for lung cancer immunotherapy
$366,580Lieping Chen · Yale University · P50 · FY2024 · CA
Separating autoimmunity and anti-tumor immunity
$366,573Isabelle Caroline Le Poole · Northwestern University At Chicago · R01 · FY2018 · CA
Protein Structure/Function by NMR, Crystallography and Computational Chemistry
$366,525Eric Oldfield · University Of Illinois At Urbana-Champaign · R01 · FY2008 · AI
Tumor suppressor p53 and its targets in checkpoint regulation
$366,502Sam W Lee · Massachusetts General Hospital · R01 · FY2017 · CA
T Cell Targeting for GVHD
$366,487Bruce R. Blazar · University Of Minnesota · R01 · FY2012 · HL
Augmenting T cell activity to weak tumor antigens and reversing myeloid cell-mediated T cell inhibition
$366,484Eduardo Davila · University Of Colorado Denver · R01 · FY2020 · CA
Augmenting T cell activity to weak tumor antigens and reversing myeloid cell-mediated T cell inhibition
$366,484Eduardo Davila · University Of Colorado Denver · R01 · FY2021 · CA
SUPPRESSION OF IMMUNOPATHOLOGY IN SCHISTOSMIASIS BY ANTI
$366,470University Of Pennsylvania · R01 · FY2000 · AI
Structural Studies of a T cell Specific Tyrosine Kinase
$366,445Amy H Andreotti · Iowa State University · R01 · FY2017 · AI
Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin Effector
$366,441Xin Lu · University Of Notre Dame · R01 · FY2020 · CA
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
$366,421Lily Yang · Emory University · R01 · FY2025 · CA
HUMAN MONOCLONAL ANTIBODIES TO STUDY AND TREAT HIV
$366,395Beth Israel Deaconess Medical Center · R01 · FY2000 · AI
Augmenting Quadruple Negative Breast Cancer Treatment by ADRM1 Inhibitor Up284
$366,390Balasubramanyam Karanam · Tuskegee University · U54 · FY2024 · MD
Immunogenic Priming with Lu-PSMA Targeted Therapy in Advanced Prostate Cancer
$366,367Rahul Aggarwal · University Of California, San Francisco · R01 · FY2019 · CA
Role of Tim-3 in determining T cell immunity
$366,335Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2019 · CA
Integrating Low-Cost Paper-Based Devices and Personalized Immunotherapeutics to Treat Triple Negative Breast Cancer
$366,308M Shahidul Islam · Delaware State University · U54 · FY2025 · MD
Quality and location of presented Ag as determinants of tumor-specific immunity
$366,307Victor H. Engelhard · University Of Virginia · R01 · FY2011 · CA
Quality and location of presented Ag as determinants of tumor-specific immunity
$366,307Victor H. Engelhard · University Of Virginia · R01 · FY2012 · CA
Role of B-cell mediated anti-tumor antibodies in responses to radiation and immunotherapy in HNSCC
$366,306Andrew B. Sharabi · University Of California, San Diego · R01 · FY2020 · DE
The role of costimulatory molecules in uveitis
$366,300Hui Shao · University Of Louisville · R01 · FY2010 · EY
Targeting cellular double-stranded RNA homeostasis in breast cancer
$366,299Cecil Han · Georgetown University · R01 · FY2023 · CA
Investigation of T cell responses to immunotherapy using class II tetramers
$366,285William W. Kwok · Benaroya Research Inst At Virginia Mason · R01 · FY2013 · AI
Brain targeted nanoparticle for Alzheimer's disease therapy
$366,250Peisheng Xu · University Of South Carolina At Columbia · R01 · FY2019 · AG
Tailoring AAV Vectors for Glioma Immunotherapy
$366,250Ou Cao · University Of Florida · R01 · FY2009 · AI
Brain targeted nanoparticle for Alzheimer's disease therapy
$366,250Peisheng Xu · University Of South Carolina At Columbia · R01 · FY2020 · AG